TrialDiabetes care2010

Impact of baseline renal function on the efficacy and safety of aliskiren added to losartan in patients with type 2 diabetes and nephropathy.

Frederik Persson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.